Why automakers are turning to hybrids in the middle of the industry's EV transition
Automakers are reconsidering the viability of hybrid vehicles to appease consumer demand and avoid costly penalties related to federal fuel economy standards.
CNBC US News
Trump PAC paid part of nearly $900,000 fee to fraud trial expert witness
An expert witness retained by the defense in the civil fraud trial of former President Donald Trump said he has been paid nearly $900,000 for his work.
The runway is getting clearer, but the U.S. economy still isn't assured of a soft landing
There's nothing about a 3.7% unemployment rate and another 199,000 jobs that even whispers "recession," let alone screams it.
How to pay off your student debt faster. 'Even an extra $5 a month can make a big difference,' expert says
You may be able to finish paying off your student debt sooner than you thought, experts say. They shared tips on how to make that happen.
Starbucks tells union it wants to resume contract talks in January
The potential restart of talks could open a window to resolve a stalemate in one of the most high-profile labor disputes in the U.S. in recent years.
Binance founder Changpeng Zhao is too rich to leave the U.S. before criminal sentencing, judge says
The ruling reverses a previous decision allowing Zhao, the crypto also known as CZ, to travel to his home in the United Arab Emirates before he is sentenced on Feb. 23.
Meta and Microsoft say they will buy AMD's new AI chip as an alternative to Nvidia's
AMD's newest AI chip, the Instinct MI300X, could give big tech buyers leverage over Nvidia, if it works as advertised and is price-competitive.
U.S. payrolls rose 199,000 in November, unemployment rate falls to 3.7%
Nonfarm payrolls were expected to increase by 190,000 in November, according to the Dow Jones consensus estimate.
Why the U.S. has a serious mining worker shortage
The U.S. has more than 12,500 active mines but an aging workforce is causing headaches for the industry.
Elon Musk considers reinstating Alex Jones' X account, backtracking on prior decision
Elon Musk said he would consider reinstating Alex Jones' X account, potentially reversing a permanent ban of the Infowars host
Here's what the market will be looking for in Friday's key jobs report
Economists expect the Labor Department to report that nonfarm payrolls expanded by 190,000 last month, up from 150,000 in October.
AMD stock spikes after company launches AI chip to rival Nvidia
For the past year, AI chips have been dominated by Nvidia, and cloud providers and technology companies have been searching for an alternative.
PayPal shares slide after Amazon drops Venmo as payment option
Amazon announced last October it would add Venmo as a payment method at checkout, giving shoppers more options to pay for their purchases.
House committee launches investigation of Harvard, MIT and UPenn over antisemitism fight
The House Education Committee is launching an investigation of Harvard, MIT and the University of Pennsylvania after recent testimony on Capitol Hill.
Biden administration asserts power to seize drug patents in move to slash high prices
The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining whether to use march-in rights.
McDonald's to open first CosMc's spinoff restaurant this week
The burger chain is positioning CosMc's as a fast, convenient way to grab a pick-me-up snack or coffee.
Amazon tests grocery subscription service for Prime members
Amazon is betting members of its $139-a-year Prime program will want to pay a separate monthly fee for unlimited grocery delivery on some orders.
Trump in court for $250 million NY fraud trial that threatens his real estate empire
Trump has railed against the case as a politically motivated witch hunt in prior appearances at Manhattan Supreme Court.
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.
Get complete CNBC business news coverage online. Find the latest regional business news pertaining to the United States of America including headlines & top stories available on the official CNBC site.
Subscribe to CNBC US News feed
#channel